Literature DB >> 19191023

Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth.

Jieying Zhao1, Guangchun Chen, Dongmei Cao, Yidong Li, Fei Diao, Haoyu Cai, Yiduo Jin, Jian Lu.   

Abstract

The failure of breast cancer treatment is largely due to the development of estrogen independence. Current data illustrate that Hedgehog (Hh) signaling may play an important role in breast cancer development. Here, we show that the expression of the Hh effector protein, Gli1 was significantly higher in estrogen-independent breast cancer cells than in estrogen-dependent cells. Our data showed for the first time that stable expression of Gli1 in ER positive breast cancer cell lines MCF-7 and T47D can induce estrogen-independent proliferation and promote G1/S phase transition, which associated with cyclin-Rb axi. Gli1 can also attenuate the response of proliferation to estrogenic stimulation, which was correlated with down-regulation of expression of ERalpha and PR, as well as down-regulation of transactivation of ERalpha. Our results suggest that up-regulation of Gli1 in breast cancer cells may be one of the mechanisms responsible for developing estrogen independence and this process may be regulated through down-regulation of expression and transactivation of ERalpha.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191023     DOI: 10.1007/s10549-009-0323-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

Review 1.  New paradigms for the Hedgehog signaling network in mammary gland development and breast Cancer.

Authors:  Teresa Monkkonen; Michael T Lewis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-06-15       Impact factor: 10.680

2.  (-)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells.

Authors:  Guo-Qing Tang; Tai-Qiang Yan; Wei Guo; Ting-Ting Ren; Chang-Liang Peng; Hui Zhao; Xin-Chang Lu; Fu-Long Zhao; Xiaoguang Han
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-02       Impact factor: 4.553

3.  Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.

Authors:  Lusheng Xu; Yeon-Jin Kwon; Natalya Frolova; Adam D Steg; Kun Yuan; Martin R Johnson; William E Grizzle; Renee A Desmond; Andra R Frost
Journal:  Breast Cancer Res Treat       Date:  2009-11-10       Impact factor: 4.872

4.  Sonic Hedgehog pathway activity in prostate cancer.

Authors:  Olga Bragina; Natalja Njunkova; Svetlana Sergejeva; Lilian Järvekülg; Priit Kogerman
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

5.  Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer.

Authors:  Yajun Tao; Jun Mao; Qingqing Zhang; Lianhong Li
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

6.  Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.

Authors:  Helen O Oladapo; Michael Tarpley; Scott J Sauer; Kezia A Addo; Shalonda M Ingram; Dillon Strepay; Ben K Ehe; Lhoucine Chdid; Michael Trinkler; Jose R Roques; David B Darr; Jodie M Fleming; Gayathri R Devi; Kevin P Williams
Journal:  Cancer Lett       Date:  2017-09-28       Impact factor: 8.679

7.  Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.

Authors:  Z I Thomas; W Gibson; J Z Sexton; K M Aird; S M Ingram; A Aldrich; H K Lyerly; G R Devi; K P Williams
Journal:  Br J Cancer       Date:  2011-04-19       Impact factor: 7.640

8.  GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state.

Authors:  Sandeep K Nadendla; Allon Hazan; Matt Ward; Lisa J Harper; Karwan Moutasim; Lucia S Bianchi; Mahmoud Naase; Lucy Ghali; Gareth J Thomas; David M Prowse; Michael P Philpott; Graham W Neill
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

9.  Combination of cyclopamine and tamoxifen promotes survival and migration of mcf-7 breast cancer cells--interaction of hedgehog-gli and estrogen receptor signaling pathways.

Authors:  Maja Sabol; Diana Trnski; Zvonimir Uzarevic; Petar Ozretic; Vesna Musani; Maja Rafaj; Mario Cindric; Sonja Levanat
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

10.  Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.

Authors:  Ying Sun; Yunshan Wang; Cong Fan; Peng Gao; Xiuwen Wang; Guangwei Wei; Junmin Wei
Journal:  Mol Cancer       Date:  2014-06-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.